We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+6.86%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$198M
AUM Growth
-$2.84M
Cap. Flow
-$11.5M
Cap. Flow %
-5.82%
Top 10 Hldgs %
37.09%
Holding
69
New
13
Increased
19
Reduced
13
Closed
21

Sector Composition

Rank Sector Weight
1 Healthcare 91.46%
2 Financials 2.33%
3 Energy 0.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IART icon
26
Integra LifeSciences
IART
$1.35B
$3.71M 1.87%
+90,000
New +$3.77M
GWPH
27
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$3.68M 1.85%
27,700
-2,300
-8% -$220K
ABBV icon
28
AbbVie
ABBV
$440B
$3.47M 1.75%
+55,000
New +$3.56M
A icon
29
Agilent Technologies
A
$42.2B
$3.3M 1.66%
70,000
-30,076
-30% -$1.4M
IPXL
30
DELISTED
Impax Laboratories, Inc.
IPXL
$3.08M 1.55%
+130,000
New +$3.49M
SHPG
31
DELISTED
Shire pic
SHPG
$2.91M 1.47%
15,000
-10,000
-40% -$1.95M
WMGI
32
DELISTED
Wright Medical Group Inc
WMGI
$2.82M 1.42%
115,000
-35,000
-23% -$806K
ILMN icon
33
Illumina
ILMN
$29.1B
$2.73M 1.37%
+15,420
New +$2.47M
SNN icon
34
Smith & Nephew
SNN
$12.6B
$2.46M 1.24%
+75,000
New +$2.52M
RVTY icon
35
Revvity
RVTY
$12.9B
$2.24M 1.13%
40,000
-10,000
-20% -$546K
CHE icon
36
Chemed
CHE
$7.05B
$2.12M 1.07%
15,000
-10,000
-40% -$1.39M
ACAD icon
37
Acadia Pharmaceuticals
ACAD
$5.07B
$2.09M 1.05%
65,577
+8,077
+14% +$274K
ZTS icon
38
Zoetis
ZTS
$31B
$1.82M 0.92%
+35,000
New +$1.77M
FMS icon
39
Fresenius Medical Care
FMS
$12.7B
$1.75M 0.88%
+40,000
New +$1.79M
LHCG
40
DELISTED
LHC Group LLC
LHCG
$1.66M 0.84%
45,000
-45,000
-50% -$1.8M
AMED
41
DELISTED
Amedisys
AMED
$1.42M 0.72%
30,000
-30,000
-50% -$1.5M
RDY icon
42
Dr. Reddy's Laboratories
RDY
$10.4B
$1.39M 0.7%
+150,000
New +$1.43M
BLUE
43
DELISTED
bluebird bio
BLUE
$1.2M 0.6%
1,364
-180
-12% -$130K
JUNO
44
DELISTED
Juno Therapeutics, Inc.
JUNO
$1.05M 0.53%
+35,000
New +$1.09M
KITE
45
DELISTED
Kite Pharma, Inc.
KITE
$838K 0.42%
15,000
-5,000
-25% -$279K
NBIX icon
46
Neurocrine Biosciences
NBIX
$16.5B
$790K 0.4%
+15,600
New +$777K
AMN icon
47
AMN Healthcare
AMN
$1.28B
-40,000
Closed -$1.6M
BMY icon
48
Bristol-Myers Squibb
BMY
$130B
-55,000
Closed -$4.04M
CYH icon
49
Community Health Systems
CYH
$405M
-150,000
Closed -$1.81M
DGX icon
50
Quest Diagnostics
DGX
$26.3B
-45,000
Closed -$3.66M

Similar funds

Sivik Global Healthcare's Q3 2016 Portfolio in Review

As of Q3 2016, Sivik Global Healthcare held 69 positions worth $198M, down 1.4% from $201M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Sivik Global Healthcare withdrew a net $11.5M in Q3 2016, closing 21 positions and reducing 13 holdings. Its most notable exit was Universal Health Services, an estimated $6.04M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, up from 90% a quarter earlier, followed by Financials and Energy.

Against the trend, Sivik Global Healthcare opened a new position in Molina Healthcare worth $4.67M.

  • Sivik Global Healthcare's largest Q3 2016 buy was Molina Healthcare: 80,000 shares worth $4.67M.
  • Sivik Global Healthcare added most to Humana in Q3 2016, an estimated $4.06M increase.
  • Sivik Global Healthcare's biggest Q3 2016 reduction was Boston Scientific, cutting an estimated $2.39M.
  • Sivik Global Healthcare fully exited Universal Health Services in Q3 2016, selling an estimated $6.04M.
  • Sivik Global Healthcare's ten largest holdings make up 37% of its $198M portfolio in Q3 2016.
  • Sivik Global Healthcare opened 13 new positions and closed 21 in Q3 2016.
  • Sivik Global Healthcare's portfolio value fell 1.4% quarter-over-quarter to $198M.

Based on Sivik Global Healthcare's 13F filing for Q3 2016, filed 14 Nov 2016.